146 related articles for article (PubMed ID: 18770045)
1. Targeted transport of 125I-labeled antibody to GFAP and AMVB1 in an experimental rat model of C6 glioma.
Chekhonin VP; Baklaushev VP; Yusubalieva GM; Gurina OI
J Neuroimmune Pharmacol; 2009 Mar; 4(1):28-34. PubMed ID: 18770045
[TBL] [Abstract][Full Text] [Related]
2. [Biodegradation of 125I-labeled monoclonal antibodies after introvenous administration to rats with experimental C6 glioma].
Chekhonina VP; Bulanov KA; Iusubalieva GM; Tsibul'kina EA; Gurina OI; Skoblov IuA; Shvets VI; Zhirkv IuA; Baklaushev VP
Biomed Khim; 2007; 53(5):532-40. PubMed ID: 18078067
[TBL] [Abstract][Full Text] [Related]
3. Modeling and immunohistochemical analysis of C6 glioma in vivo.
Chekhonin VP; Baklaushev VP; Yusubalieva GM; Pavlov KA; Ukhova OV; Gurina OI
Bull Exp Biol Med; 2007 Apr; 143(4):501-9. PubMed ID: 18214311
[TBL] [Abstract][Full Text] [Related]
4. A targeted transport of 125I-labeled monoclonal antibodies to target proteins in experimental glioma focus.
Chekhonin VP; Baklaushev VP; Yusubalieva GM; Gurina OI; Dmitrieva TB
Dokl Biochem Biophys; 2008; 418():40-3. PubMed ID: 18429604
[No Abstract] [Full Text] [Related]
5. Targeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43.
Chekhonin VP; Baklaushev VP; Yusubalieva GM; Belorusova AE; Gulyaev MV; Tsitrin EB; Grinenko NF; Gurina OI; Pirogov YA
Nanomedicine; 2012 Jan; 8(1):63-70. PubMed ID: 21703991
[TBL] [Abstract][Full Text] [Related]
6. [Antibodies to glial fibrillary antigen as potential carriers of drugs for glial tumors].
Obukhov SK; Kalashnikova VV; Khalanskiĭ AS
Zh Vopr Neirokhir Im N N Burdenko; 1989; (2):30-2. PubMed ID: 2787569
[TBL] [Abstract][Full Text] [Related]
7. Visualization of Connexin 43-positive cells of glioma and the periglioma zone by means of intravenously injected monoclonal antibodies.
Baklaushev VP; Yusubalieva GM; Tsitrin EB; Gurina OI; Grinenko NP; Victorov IV; Chekhonin VP
Drug Deliv; 2011 Jul; 18(5):331-7. PubMed ID: 21309693
[TBL] [Abstract][Full Text] [Related]
8. [The distribution of glial fibrillary acidic protein and protein S-100 in experimental brain tumors in rats].
Khalanskiĭ AS; Shevchenko GM; Berezin VA
Zh Vopr Neirokhir Im N N Burdenko; 1991; (1):19-22. PubMed ID: 1649519
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of neuropoiesis generating glial progenitors that infiltrate rat intracranial glioma.
Duntsch C; Zhou Q; Weimar JD; Frankel B; Robertson JH; Pourmotabbed T
J Neurooncol; 2005 Feb; 71(3):245-55. PubMed ID: 15735912
[TBL] [Abstract][Full Text] [Related]
10. Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines.
Reifenberger G; Bilzer T; Seitz RJ; Wechsler W
Acta Neuropathol; 1989; 78(3):270-82. PubMed ID: 2475009
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging of intracranial human glioma xenografts comparing specific with nonspecific radiolabeled monoclonal antibodies.
Bullard DE; Adams CJ; Coleman RE; Bigner DD
J Neurosurg; 1986 Feb; 64(2):257-62. PubMed ID: 3944636
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data.
Stavrou D; Mellert W; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P
Anticancer Res; 1985; 5(2):147-56. PubMed ID: 3994308
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of antisera and of murine monoclonal antibodies to human glioma-associated antigen(s).
Matsuda M; Fischer DK; Narayan RK; Atassi MZ
Adv Exp Med Biol; 1991; 303():271-83. PubMed ID: 1805572
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous demonstration of glia- and glioma-associated antigens in human astrocytomas.
Bilzer T; Martin B; Stavrou D; Keiditsch E
Int J Cancer Suppl; 1988; 2():41-4. PubMed ID: 3162445
[TBL] [Abstract][Full Text] [Related]
15. Expression of GFAP (glial fibrillary acidic protein) antigenicity and differentiation of glioma tumor cells of astrocytic origin.
Kałuza J; Adamek D
Folia Histochem Cytobiol; 1990; 28(3):155-9. PubMed ID: 2096082
[TBL] [Abstract][Full Text] [Related]
16. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade.
Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB
Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947
[TBL] [Abstract][Full Text] [Related]
17. [Histologic distribution of anti-glioma monoclonal antibody SZ-39 in human xenograft brain tumors].
Yang WL
Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):82-4. PubMed ID: 2806047
[TBL] [Abstract][Full Text] [Related]
18. Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4.
Yang W; Barth RF; Wu G; Ciesielski MJ; Fenstermaker RA; Moffat BA; Ross BD; Wikstrand CJ
Clin Cancer Res; 2005 Jan; 11(1):341-50. PubMed ID: 15671565
[TBL] [Abstract][Full Text] [Related]
19. Distribution of labelled anti-tenascin antibodies and fragments after injection into intact or partly resected C6-gliomas in rats.
Goetz CM; Rachinger W; Decker M; Gildehaus FJ; Stocker S; Jung G; Tatsch K; Tonn JC; Reulen HJ
Cancer Immunol Immunother; 2005 Apr; 54(4):337-44. PubMed ID: 15449040
[TBL] [Abstract][Full Text] [Related]
20. In vitro efficacy of anti-glial fibrillary acidic protein monoclonal antibodies against human malignant glioma cell lines.
Abaza MS; Narayan RK; Atassi MZ
Jpn J Cancer Res; 1997 Nov; 88(11):1094-9. PubMed ID: 9439685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
